CDISCの概要と 普及への取り組みについて
SDTM/ADaM仕様作成実績. 注： PMDA. に申請予定あるいは申請済みの薬剤開発プロジェクト対象（国外組織あるい は外部業者に作成依頼した場合も含む）。 1) 0. 2) 1 ～ 5 3) 6 ～10 4) 11 ～ 15 5) 16 ～ SDTM_Spec. 37. 13. 4. 2. 10. 0. 5. 10. 15. 20. 25. 30. 35. 40. SDTM. 仕様書作成試験 …
Download CDISCの概要と 普及への取り組みについて
Information
Domain:
Source:
Link to this page:
Documents from same domain
339 - pmda.go.jp
www.pmda.go.jp医薬品・医療機器等安全性情報 No.339 −3− 2016年12月 1 ミルナシプラン塩酸塩，デュロキセチン塩酸塩 及びベンラファキシン塩酸塩製剤の自動車運転等
Report on the Deliberation Results - pmda.go.jp
www.pmda.go.jpReport on the Deliberation Results . December 3, 2014 . Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau . Ministry of Health, Labour and Welfare
Filgrastim, Lenograstim, Nartograstim, Pegfilgrastim
www.pmda.go.jpPharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of
Pharmaceuticals and Medical Devices Safety …
www.pmda.go.jpPharmaceuticals and Medical Devices Safety Information No. 347 - 3 - October 2017 Abbreviations ADR Adverse drug reaction Alb Albumin ALP Alkaline phosphatase
The Ministry of Health, Labour and Welfare …
www.pmda.go.jpThe Ministry of Health, Labour and Welfare Ministerial Notification No. 519 Pursuant to Paragraph 1, Article 41 of the Pharmaceutical AŠairs Law (Law No.
2018.3 No. 267 - pmda.go.jp
www.pmda.go.jp1 2018. 3. dsu no. 267 重 要 生薬 510 サンシシ 2 漢方製剤 520 茵蔯蒿湯 3 温清飲 4 黄連解毒湯 3 加味帰脾湯 4
PMDA HP
www.pmda.go.jp後発医薬品品質情報 no.9 4 独立行政法人医薬品医療機器総合機構（pmda）では、本誌情報やジェネリック医薬品品質情報検討会の
PMDAからの医薬品適正使用のお願い - pmda.go.jp
www.pmda.go.jp医薬品医療機器総合機構PMDA. からの医薬品適正使用のお願い http://www.pmda.go.jp/safety/info-services/drugs/0001.html
IMPURITIES GUIDELINE FOR RESIDUAL S Q3C(R5)
www.pmda.go.jpinternational conference on harmonisation of technical requirements for registration of pharmaceuticals for human use ich harmonised tripartite guideline impurities: guideline for …
2.7.2 summary of clinical pharmacology Studies
www.pmda.go.jpCONFIDENTIAL RM2003/00379/00 2.7.2 Summary of Clinical Pharmacology 4 ABBREVIATIONS 3TC lamivudine (EPIVIRƒ) ABC abacavir (ZIAGENƒ)AE Adverse Event AUC0-t,ss Area under the drug concentration-time curve from 0 to time t at steady state AUC∞ Area under the plasma concentration versus time curve from time 0 and …
Related documents
Study Data Tabulation Model Implementation Guide: Human ...
www.sastricks.comStudy Data Tabulation Model Implementation Guide: Human Clinical Trials Version 3.3 (Final) Prepared by the CDISC Submission Data Standards Team
A Brief Introducon to CDISC – SDTM and Data Mapping
www.cytel.comCharacteriscs of SDTM Domains Domains – 1. Domain: Collecon of observaons with common topic. Generally each domain is represented by a dataset. 2. Each domain has a unique two‐character domain name (e.g., AE, CM, VS) 3. Variables in domain begin with the domain